News
Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
King of Prussia, PA – December 13, 2022: RBQM leader, CluePoints, has today announced Andy Cooper has...
Read
Risk-based approaches to monitoring clinical trials were brought to the forefront with an FDA guidance...
Read
Key risk indicators (KRIs) are metrics designed to identify risks of specific interest to study teams...
Read
The success of clinical development programmes, drug approval and marketing depends ultimately on the...
Read
Central monitoring, which typically includes the use of key risk indicators (KRIs), aims at improving...
Read
King of Prussia, PA – October 12th, 2022: Risk-based quality management (RBQM) solutions provider, CluePoints,...
Read